comprehensive -WSS

comprehensive

author：hotspot 2025-09-30 15:22:25 - browse：8

Stock photo of a surgeon holding a digital tablet in a medical setting – health tech coverage from STAT — Adobe

A new $50 million nonprofit initiative aims to independently evaluate health technologies’ impact on costs and quality, an attempt to help patients, payers, and providers sort over-hyped products from ones that actually move the needle.

The Peterson Center on Healthcare, a nonprofit supporting programs that raise care quality and drive down costs, announced the new Peterson Health Technology Institute Tuesday. The institute plans to publish its methodology for assessing new health technology as soon as September, and start publishing reports on specific sectors, like disease types or tech mechanisms, in 2024, executive director Caroline Pearson told STAT.

Especially after digital health investment surged early in the pandemic, health apps and software have proliferated — both those marketed to consumers and designed for organizations like health systems or insurers. Venture funding has since contracted, but customers are still faced with “an overwhelming number of solutions,” Pearson said. “It’s hard to know what is high value in this space.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Abortion policy in the spotlight at Republican debate

Wikipedia

WSS

Intellia plays down concerns on accidental germline transmission

FDA approves updated Covid vaccines

Acelyrin, a rare IPO success, stumbles in its first big test

Diverse clinical trials: Why aren’t we there yet?

How to make over

Popular nasal decongestant doesn't actually relieve congestion

knowledge

comprehensive

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

PEPFAR is under serious threat — and so is global health

Medicare details structure of new drug price negotiation program

Intellia plays down concerns on accidental germline transmission

Peter Hotez and the public health issue of online harassment

Diverse clinical trials: Why aren’t we there yet?

Heart attack and stroke risk calculators need revising

Vivek Ramaswamy made waves in the debate, much as in biotech

Medicare details structure of new drug price negotiation program

Meadows told special counsel he could not recall Trump ever declassifying Mar

focus

Health officials lay out plans to cope with respiratory virus season

Meadows told special counsel he could not recall Trump ever declassifying Mar

FDA proposes changes to key medical devices approval pathway

Walmart eyes Medicare Advantage provider ChenMed

Trans patients at the end of life deserve respect and dignity

California store owner shot dead in dispute over displaying Pride flag: Police

focus

Wikipedia

leisure time

focus